https://www.selleckchem.com/pr....oducts/dual-specific
articularly important as the therapeutic landscape for RA continues to evolve. We observed a conservative trend with TNFi as the main therapeutic choice for patients with RA and inadequate response to MTX. Preference for bDMARD-based strategies increased with the number of RA-poor prognosis factors, whereas an increase in the number of comorbidities resulted in an increased preference for ABA. Understanding clinical decision-making will be particularly important as the therapeutic landscape
Aimer
Commentaire
Partagez
Palak Nayyar
https://tv-sound-monitors.phil....ips.com/s/question/0
https://tv-sound-monitors.phil....ips.com/s/question/0
https://tv-sound-monitors.phil....ips.com/s/question/0
supprimer les commentaires
Etes-vous sûr que vous voulez supprimer ce commentaire ?